Dr. Bradley Miller, M.D

NPI: 1184633059
Total Payments
$567,210
2024 Payments
$50,831
Companies
23
Transactions
414

Payment Breakdown by Category

Consulting$239,970 (42.3%)
Travel$166,973 (29.4%)
Other$105,370 (18.6%)
Food & Beverage$35,834 (6.3%)
Research$17,060 (3.0%)
Education$2,003 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $239,970 99 42.3%
Travel and Lodging $166,973 138 29.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,402 35 13.3%
Food and Beverage $35,834 119 6.3%
Honoraria $29,968 11 5.3%
Unspecified $17,060 10 3.0%
Education $2,003 2 0.4%

Payments by Type

General
$550,150
404 transactions
Research
$17,060
10 transactions

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Health Care AG $128,691 73 $0 (2024)
Hexal AG $104,157 56 $0 (2020)
PFIZER INC. $56,960 32 $0 (2023)
Novo Nordisk AS $53,359 26 $0 (2024)
Novo Nordisk Inc $53,281 59 $0 (2023)
BioMarin Pharmaceutical Inc. $47,744 61 $0 (2024)
Ascendis Pharma Inc $25,741 21 $0 (2023)
TOLMAR Pharmaceuticals, Inc. $20,111 16 $0 (2022)
GENZYME CORPORATION $18,769 18 $0 (2020)
Tolmar, Inc. $13,740 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $50,831 43 Novo Nordisk Health Care AG ($18,293)
2023 $159,234 115 Novo Nordisk Health Care AG ($29,566)
2022 $57,415 35 Novo Nordisk Health Care AG ($26,082)
2021 $41,710 26 Novo Nordisk Health Care AG ($11,400)
2020 $31,292 26 Hexal AG ($10,327)
2019 $62,547 66 Novo Nordisk Health Care AG ($15,720)
2018 $84,112 58 Hexal AG ($39,636)
2017 $80,068 45 Hexal AG ($44,284)

All Payment Transactions

414 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
11/27/2024 Novo Nordisk AS Travel and Lodging In-kind items and services $7,876.81 General
11/27/2024 Novo Nordisk AS Consulting Fee Cash or cash equivalent $6,300.00 General
11/27/2024 Novo Nordisk AS Travel and Lodging In-kind items and services $367.58 General
11/27/2024 Novo Nordisk AS Travel and Lodging In-kind items and services $299.87 General
11/27/2024 Novo Nordisk AS Food and Beverage In-kind items and services $220.56 General
11/27/2024 Novo Nordisk AS Travel and Lodging In-kind items and services $34.84 General
11/27/2024 Novo Nordisk AS Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $15.00 General
11/19/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $4,300.00 General
11/19/2024 Novo Nordisk Health Care AG Travel and Lodging In-kind items and services $551.98 General
11/19/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $400.00 General
11/19/2024 Novo Nordisk Health Care AG Food and Beverage In-kind items and services $253.98 General
11/19/2024 Novo Nordisk Health Care AG Travel and Lodging In-kind items and services $169.54 General
11/18/2024 Tolmar, Inc. FENSOLVI (Drug) Food and Beverage Cash or cash equivalent $29.28 General
Category: HORMONE REPLACEMENT
11/16/2024 Novo Nordisk Health Care AG Sogroya (Biological) Consulting Fee Cash or cash equivalent $5,100.00 General
Category: Growth Hormone
11/16/2024 Novo Nordisk Health Care AG Sogroya (Biological) Travel and Lodging In-kind items and services $4,430.27 General
Category: Growth Hormone
11/16/2024 Novo Nordisk Health Care AG Sogroya (Biological) Travel and Lodging In-kind items and services $1,310.46 General
Category: Growth Hormone
11/16/2024 Novo Nordisk Health Care AG Sogroya (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $681.29 General
Category: Growth Hormone
11/16/2024 Novo Nordisk Health Care AG Sogroya (Biological) Travel and Lodging In-kind items and services $255.92 General
Category: Growth Hormone
11/16/2024 BioMarin Pharmaceutical Inc. VOXZOGO 1.2mg (Drug) Food and Beverage In-kind items and services $74.14 General
Category: Achondroplasia
09/24/2024 Amgen Inc. PROCYSBI (Biological) Consulting Fee Cash or cash equivalent $1,740.00 General
Category: Inflammation/Rare Disease
06/02/2024 Novo Nordisk Health Care AG Sogroya (Biological) Food and Beverage In-kind items and services $40.00 General
Category: Growth Hormone
05/31/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $800.00 General
05/02/2024 BioMarin Pharmaceutical Inc. VOXZOGO 1.2mg (Drug) Food and Beverage In-kind items and services $227.79 General
Category: Achondroplasia

Research Studies & Clinical Trials

Study Name Company Amount Records
MOD4023 OPKO CLINICAL PUBLICATION PROGRAM PFIZER INC. $8,610 5
SOMATROGON CLINICAL PUBLICATION PROGRAM PFIZER INC. $5,250 4
NGENLA CLINICAL PUBLICATION PROGRAM PFIZER INC. $3,200 1

About Dr. Bradley Miller, M.D

Dr. Bradley Miller, M.D is a Pediatrics healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184633059.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Miller, M.D has received a total of $567,210 in payments from pharmaceutical and medical device companies, with $50,831 received in 2024. These payments were reported across 414 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($239,970).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Endocrinology
  • Location Minneapolis, MN
  • Active Since 08/07/2006
  • Last Updated 04/23/2015
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1184633059

Products in Payments

  • Omnitrope (Drug) $104,157
  • Norditropin (Drug) $67,549
  • Norditropin (Biological) $61,840
  • GENOTROPIN (Drug) $33,309
  • Sogroya (Biological) $30,878
  • FENSOLVI (Drug) $26,992
  • SKYTROFA (Drug) $13,716
  • NO PRODUCT DISCUSSED (Drug) $8,967
  • TZIELD (Biological) $8,593
  • PROCYSBI (Biological) $7,957
  • VOXZOGO 1.2mg (Biological) $7,421
  • ELIGARD (Drug) $6,859
  • VOXZOGO 1.2mg (Drug) $5,819
  • Diazoxide Choline Controlled Release (DCCR) (Drug) $5,435
  • Thyquidity (Drug) $4,000
  • ALDURAZYME (Drug) $3,377
  • NGENLA (Drug) $2,789
  • SUPPRELIN (Drug) $2,405
  • OMNITROPE (Drug) $2,319
  • INCRELEX (Drug) $2,000

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Minneapolis